AzTrials
AzTrials

Edentulous Alveolar RidgeNCT05340959

Evaluating Implant Stability Using Three Devices Osstell®, Periotest® and AnyCheck®

An observational study of Edentulous Alveolar Ridge, run by University of Baghdad at 1 site in Iraq.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A prospective observational study guided by the guidelines of Strengthening The Reporting Of Observational Study in Epidemiology (STROBE) in 2014, that will be conducted to evaluate implant stability using three devices; Osstell®, Peiotest® and AnyCheck® and comparing the results. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Edentulous Alveolar Ridge
What is being tested?
Devices: Osstell®, Periotest® and AnyCheck®.
Type of treatment
Medical device
How many people
16 participants
Where
1 siteIraq
Study dates
15 Dec 2021to 1 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy adults with missing one or more tooth or teeth seeking for dental implant treatment.

Who may be able to join

  • Healthy patients over 18 years of either gender, having single or multiple missing teeth in the maxilla and/or mandible.
  • Patient with adequate vertical bone height and width for implant placement based on preoperative radiographic findings (CBCT).
  • Ability to tolerate conventional surgical and restorative procedures.
  • Patients who are willing to comply with the study and give their consent.

Who cannot join

  • Active infection or inflammation in the implant zone.
  • Presence of any uncontrolled systemic diseases.
  • Patients with a history of radiotherapy to the head and neck.
  • Any patient requires advanced and complicated surgical techniques such as sinus lift and bone graft.

Trial locations and contacts

1 site in 1 country.

Iraq1 site
  • College of Dentistry, University of Baghdad

    Baghdad, Medical City, 1417

Other trials in Iraq

About this study

Official title: Evaluating Implant Stability Using Three Devices Osstell®, Periotest® and AnyCheck®: A Prospective Observational Clinical Study.

A prospective observational study guided by the guidelines of Strengthening The Reporting Of Observational Study in Epidemiology (STROBE) in 2014, that will be conducted to evaluate implant stability using three devices; Osstell®, Peiotest® and AnyCheck® and comparing the results.

Read the detailed description

In this study, 40 dental implants will be installed in osteotomy sites for patients with single or multiple missing tooth or teeth based on radiographic findings (CBCT).

The primary stability will be measured immediately after implant installation using three devices :

  1. Osstell : based on resonance frequency analysis (RFA).
  2. Periotest: based on damping effect.
  3. AnyCheck: based on tapping motion. Secondary stability will be measured after 12 weeks using the same devices mentioned above.
Being tested
Devices: Osstell®, Periotest® and AnyCheck®.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Devices: Osstell®, Periotest® and AnyCheck®.Device

    1. Osstell®: is a device that measure implant stability and based on resonance frequency analysis (RFA). Due to stiffness in the interface between the implant surface and the bone smart peg will vibrates accordingly. the more dense bone the higher stability, the higher frequency and higher Implant Stability Quotient (ISQ) value which is from 1-100.
    2. Periotest®: is a device used to assess osseointegration of dental implants, so it measure implant stability . it is based on damping effect of implant. Showing the measurement digitally on a scale from -8 (low mobility) to 50 (high mobility) PTV units.
    3. AnyCheck®: this is an implant stability meter that measures the stiffness of alveolar bone-implant interface through a tapping motion. Showing the measurement on a scale from 30 (low stability) to 85 (high stability).
Study groups in NCT05340959
Study groupRoleWhat they receive
Adult patient with single or multiple missing tooth or teeth requiring dental implantsAdult patient with single or multiple missing tooth or teeth requiring dental implants, 40 dental implants will be placed in osteotomy sites based on radiographic findings (CBCT), the primary stability will be measured immediately after implant installation and secondary stability will be measured after 12 weeks . Both primary and secondary stability will be measured by three devices: 1. Osstell®: based on Resonance Frequency Analysis (RFA). 2. Periotest®: based on damping effect. 3. AnyCheck®: based on tapping-motion.
Receives: Device: Devices: Osstell®, Periotest® and AnyCheck®.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Implant stability measured by Osstell®.

    Implant stability will be measured by:

    Osstell® (RFA) that is measured by Implant Stability Quotient (ISQ) Value.

    Measured: Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).

  2. Implant stability measured by Periotest®.

    Implant stability will be measured by:

    Periotest® (damping effect) that is measured by Periotest Value (PTV).

    Measured: Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).

  3. Implant stability measured by AnyCheck®.

    Implant stability will be measured by:

    AnyCheck® (tapping-motion) that is measured by Initial Stability Test (IST) Value.

    Measured: Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).

  4. Correlation between values obtained by the devices

    Correlation between values obtained by:

    1. Osstell® (RFA): measured by Implant Stability Quotient (ISQ) Value.
    2. Periotest® (damping effect): measured by Periotest Value (PTV).
    3. AnyCheck® (tapping-motion): measured by Initial Stability Test (IST) Value.

    Measured: Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2022
  2. Study start15 Dec 2021
  3. Primary completion1 Sep 2022
  4. Study completion1 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05340959
Sponsor's protocol ID
41193
Status last verified
Oct 2023
First submitted
27 Mar 2022
Last updated
3 Oct 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Edentulous Alveolar Ridge, run by University of Baghdad at 1 site in Iraq.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Implant stability measured by Osstell®. (time frame: Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in